
USA Today
<img alt="" height="1" width="1" />
FDA staff recommends against J&J clotting drug
BusinessWeek
A bad review from Food and Drug Administration staff bodes ill for a Johnson & Johnson blood thinner. An FDA staff report released Tuesday recommends against approving Xarelto for preventing strokes in patients with a common irregular heart rhythm. ...
FDA Recommends Against Bayer and J&J Anti-Clot DrugInternational Business Times
Bayer, J&J Suffer FDA SetbackWall Street Journal
New J&J medicine gets negative FDA reviewLansing State Journal
Toronto Star -Bloomberg -Forbes
all 231 news articles »
More...